#331Extended selection 101–500
MannKind Corporation
Mid-Atlantic / Southeast
Peptides and metabolic medicinesDrug delivery and Medical Devices
Manufacturing profile
Peptides and metabolic medicines
Drug delivery and Medical Devices
Biopharma hub: Mid-Atlantic / Southeast
Selection basis
The company is placed in positions 101–500 as a manufacturer, biotech, generics, advanced-therapy company or CDMO with practical relevance to the FUZKK utility catalog.
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Representative manufacturing and QC chain
- 1Peptide synthesis or recombinant upstream
- 2Chromatography and UF/DF
- 3HPLC/LC-MS and CE peptide mapping
- 4Sterile filtration and cartridge/vial filling
- 5Particles, sterility, endotoxin and cold-chain release
- 6Design inputs and risk management
- 7Supplier and incoming controls
- 8Assembly and process validation
- 9Software, usability and cybersecurity
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Medical Devices — equipment and software lifecycle
Design Control Compliance CheckerRisk Management Report Completeness CheckerRisk Control Traceability CheckerRequirement Traceability CheckerSoftware Safety Class CheckerData Integrity Security CheckerCybersecurity Risk Assessment CheckerElectrical Safety Test Summary CheckerEMCTest Coverage CheckerUDIData Completeness CheckerPackaging Integrity CheckerSterility Assurance Level Checker
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Methodology